Intravenous beta-adrenoblocker therapy in acute coronary syndrome patients

Early treatment optimization improves clinical outcomes and reduces morbidity and mortality in patients with acute myocardial infarction (AMI). Intravenous beta-adrenoblocker (BAB) therapy, associated with improved survival, is well tolerated by AMI patients. The results of relevant clinical trials...

Cijeli opis

Bibliografski detalji

Glavni autori:	S. N. Tereshchenko, I. V. Zhirov
Format:	Artigo
Jezik:	Russo
Izdano:	«SILICEA-POLIGRAF» LLC 1970-01-01
Serija:	Кардиоваскулярная терапия и профилактика
Teme:	acute myocardial infarction beta-adrenoblockers cardiogenic shock genetic polymorphism
Online pristup:	https://cardiovascular.elpub.ru/jour/article/view/1497
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!